Two Sigma Ventures

Tracked participation in 3 Atlas companies, with 2 explicitly attributed leads.

3portfolio companies

6round participations

2lead positions

$40Mled round total

Conviction

Most recent leads

The latest rounds this investor is sourced as leading, newest first.

Jan 2021Terray TherapeuticsSeed$20M UndatedTerray TherapeuticsSeed (previously unannounced)$20M

Capital activity

Portfolio

CompanyLatest valuationFirst → latestRoundsRoleAttributed partner

TTTerray Therapeutics—Jan 2021 → Oct 20244 rounds2 ledDusan Perovic

XTXaira Therapeutics—Apr 2024 → Apr 20241 roundParticipant—

RRecursionScienceRecursion is a clinical-stage TechBio company building an industrialized, AI-native drug discovery and development…$938.3MraisedRecent roundsPublic offering (underwritten) · Jun 2024$200M · Public shareholders (offering investors)Strategic investment (private investment in public equity / PIPE) · Jul 2023$50M · led by NVIDIAInitial Public Offering (IPO) / Public offering (pricing) · Apr 2021$436.4M · Baillie Gifford & Co. (clients incl. Scottish Mortgage Investment Trust plc), Mubadala Investment Company (entities affiliated) +1Recursion—Sep 2020 → Sep 20201 roundParticipant—

DateCompanyRoundRaisedValuationRoleEvidence

Oct 17, 2024TTTerray TherapeuticsSeries B$120M—Participant

Source ↗

Apr 24, 2024XTXaira TherapeuticsSeries A (stealth launch / incubated by co-leads)$1B—Participant

Source ↗

Feb 15, 2022TTTerray TherapeuticsSeries A$60M—Participant · Dusan Perovic

Source ↗

Jan 01, 2021TTTerray TherapeuticsSeed$20M—Lead

Source ↗

Sep 09, 2020RRecursionScienceRecursion is a clinical-stage TechBio company building an industrialized, AI-native drug discovery and development…$938.3MraisedRecent roundsPublic offering (underwritten) · Jun 2024$200M · Public shareholders (offering investors)Strategic investment (private investment in public equity / PIPE) · Jul 2023$50M · led by NVIDIAInitial Public Offering (IPO) / Public offering (pricing) · Apr 2021$436.4M · Baillie Gifford & Co. (clients incl. Scottish Mortgage Investment Trust plc), Mubadala Investment Company (entities affiliated) +1RecursionSeries D$239M—Participant

Source ↗+1 ↗

UndatedTTTerray TherapeuticsSeed (previously unannounced)$20M—Lead · Dusan Perovic

Source ↗

DateCompanyRoundRaisedValuationRoleEvidence

Apr 24, 2024XTXaira TherapeuticsSeries A (stealth launch / incubated by co-leads)$1B—Participant

Source ↗

Source ↗+1 ↗

Oct 17, 2024TTTerray TherapeuticsSeries B$120M—Participant

Source ↗

Feb 15, 2022TTTerray TherapeuticsSeries A$60M—Participant · Dusan Perovic

Source ↗

Jan 01, 2021TTTerray TherapeuticsSeed$20M—Lead

Source ↗

UndatedTTTerray TherapeuticsSeed (previously unannounced)$20M—Lead · Dusan Perovic

Source ↗